Multiple Sclerosis Clinical Trials
109 studies are recruiting for multiple sclerosis in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 4
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
In this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease trajectory and treatment response and pave the way for realizing precision medicine in MS. Because MS is a chronic neur…
- Stage
- Not phased
- Ages
- 7 and older
- Site
- University of Pittsburgh, Pittsburgh, Pennsylvania
- Run by
- University of Pittsburgh
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking …
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- Kessler Foundation, West Orange, New Jersey
- Run by
- Kessler Foundation
-
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
The goal of the study is to learn about treating older people with multiple sclerosis (MS) with metformin. Metformin may be used as a single therapy or as an add-on therapy. The investigators want to learn: * The safety and tolerability of metformin extended release (1500 mg/day) as a single therap…
- Stage
- Phase 2
- Ages
- 55 to 75
- Site
- UBMD Neurolgy, Buffalo, New York
- Run by
- State University of New York at Buffalo
-
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
The purpose of this study is to provide information on maternal, fetal, and infant outcomes following exposure of ozanimod during pregnancy so that participants and physicians can weigh the benefits and risks of exposure to the pharmaceutical during pregnancy and make informed treatment decisions.
- Stage
- Not phased
- Ages
- Any age
- Site
- Evidera INC., Bethesda, Maryland
- Locations
- 3 in total
- Run by
- Bristol-Myers Squibb
-
NARCOMS Registry: A Multiple Sclerosis Registry
This project is based on the idea that we can learn about the complexities of MS by following disease and treatment patterns in a large group of people over several years. The information gathered is used for research only. Results are presented in summary form only. All details submitted by regist…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UT Southwestern Medical Center, Dallas, Texas
- Run by
- University of Texas Southwestern Medical Center
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
People with Multiple Sclerosis (MS) often experience cognitive difficulties such as memory problems, concentration issues, and reduced processing speed. These symptoms can have a negative impact on daily functioning and overall quality of life. Previous research on cognitive rehabilitation has show…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- Health, Medical and Neuropsychology, Institute of Psychology, Faculty of Behvavioural and Social Siences, Leiden University, Leiden,
- Locations
- 3 in total
- Run by
- Universiteit Leiden
-
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
The goal of this observational study is to validate a novel, cost-effective method for real-world assessment using patient-acquired "selfie" videos in people with multiple sclerosis. The investigators aim to prove the feasibility and validity of monitoring walking changes remotely through a truly p…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of California, San Francisco, San Francisco, California
- Run by
- University of California, San Francisco
-
HOBSCOTCH-MS-Efficacy Trial
The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-MS to improve the quality of life and cognitive function in Service Members, Veterans and civilians who have multiple sclerosis with cognitive and memory problems (MS participants). This study will also ass…
- Stage
- Not phased
- Ages
- 20 to 75
- Site
- Dartmouth-Health Lebanon, Lebanon, New Hampshire
- Run by
- Dartmouth-Hitchcock Medical Center
-
A Study of the MIND Diet for Persons With Multiple Sclerosis
This study will assess the impact of a MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet on brain health and MS symptoms. Participants will be randomly assigned to one of two arms: the diet intervention arm or the "continue current diet"/control arm. Participants randomized to…
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- Mount Sinai Hospital, New York, New York
- Run by
- Icahn School of Medicine at Mount Sinai
-
Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection
The objective of this RCT is to assess the efficacy of one-on-one telehealth CBT-I (tCBT-I) compared to web-based CBT-I (wCBT-I) and treatment as usual (TAU) to improve sleep outcomes (Aim 1), fatigue and quality of life (Aim 2), and promote neuroprotection (Exploratory Aim 3), and to explore the c…
- Stage
- Phase 2
- Ages
- 18 to 65
- Site
- University of Kansas Medical Center- Sleep, Health and Wellness Laboratory, Kansas City, Kansas
- Run by
- University of Kansas Medical Center
-
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).
- Stage
- Not phased
- Ages
- 22 to 75
- Site
- Cleveland State University, Cleveland, Ohio
- Run by
- Cionic, Inc.
-
Vancomycin Study in Multiple Sclerosis (MS)
The overall goal of this study is to elucidate a mechanism by which vancomycin modulates the gut-brain axis in multiple sclerosis (MS). The gut microbiome plays an important role in autoimmunity, including MS. However, the identity of gut microbes modulating neuroinflammation in MS and their mechan…
- Stage
- Phase 1
- Ages
- 18 to 50
- Site
- Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York, New York
- Run by
- Icahn School of Medicine at Mount Sinai
-
An Individualized-health eLibrary App for People With Multiple Sclerosis
The purpose of this study is to assess the effectiveness after using a new individualized-health e-library app named SavvyHealth among people with multiple sclerosis.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Illinois Urbana-Champaign, Champaign, Illinois
- Run by
- University of Illinois at Urbana-Champaign
-
Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension
The goal of this study is to determine if 12 weeks of cycling exercise training at home will improve three parameters: 1) blood pressure, 2) cognition, and 3) walking ability among persons with multiple sclerosis who have high blood pressure, when compared to a group that engages in a 12-week home-…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UMass Boston, Boston, Massachusetts
- Run by
- University of Massachusetts, Boston
-
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- 354 School of Health Professions Building, Birmingham, Alabama
- Run by
- University of Alabama at Birmingham
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosi…
- Stage
- Not phased
- Ages
- 18 to 89
- Site
- Emory Univeristy, Atlanta, Georgia
- Run by
- Emory University
-
Dry Needling in Multiple Sclerosis
The investigators are doing this study to see if a treatment called dry needling improves muscle spasticity (muscle tightness) in people who have Multiple Sclerosis. Dry needling involves using tiny needles, like those in acupuncture, to target some muscles, like calf muscles. It differs from tradi…
- Stage
- Not phased
- Ages
- 18 to 64
- Site
- Mobility and Falls Lab, Kansas City, Kansas
- Run by
- University of Kansas Medical Center
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
Rationale: The Balance-Based Torso-Weighting (BBTW) is a patented evaluation system that uses strategic placement of small or lightweight weights on the trunk to improve balance and stability. BBTW has been found to improve the upright mobility of people with multiple sclerosis, however the mechani…
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- University of St. Augustine for Health Sciences, Saint Augustine, Florida
- Run by
- University of St. Augustine for Health Sciences
-
NYSCF Scientific Discovery Biobank
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store th…
- Stage
- Not phased
- Ages
- 0 and older
- Site
- New York Stem Cell Foundation Research Institute, New York, New York
- Run by
- New York Stem Cell Foundation Research Institute
-
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
Our overall objective is to obtain an initial assessment of the potential value of using [18F]3F4AP for imaging demyelinating diseases such as multiple sclerosis: * Aim 1) Assess the safety of [18F]3F4AP in healthy volunteers and subjects with multiple sclerosis (MS). Hypothesis 1: Administration o…
- Stage
- Phase 1
- Ages
- 18 to 65
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community
Cognitive impairments are common in multiple sclerosis (MS) diagnosed both at the onset and throughout the disease course. Poor cognitive abilities have been associated with poor outcomes such as higher levels of unemployment, poor quality of life, driving difficulties among others. Learning and me…
- Stage
- Not phased
- Ages
- 19 to 65
- Site
- Kessler Foundation, East Hanover, New Jersey
- Run by
- Kessler Foundation
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their…
- Stage
- Not phased
- Ages
- Any age
- Site
- Accelerated Cure Project, Waltham, Massachusetts
- Run by
- Accelerated Cure Project for Multiple Sclerosis
-
Kesimpta (Ofatumumab) Pregnancy Registry
The Kesimpta Pregnancy Registry is an observational, exposure cohort designed study to examine pregnancy and infant outcomes in women and infants who are exposed to Kesimpta (ofatumumab) during pregnancy to treat MS.
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- University of California San Diego OTIS, La Jolla, California
- Run by
- Novartis Pharmaceuticals
-
Entire-body PET Scans for Multiple Sclerosis
To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.
- Stage
- EARLY_Phase 1
- Ages
- 25 to 55
- Site
- Brain Health Alliance, Ladera Ranch, California
- Run by
- Brain Health Alliance
-
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
The objective of the randomized, sham-controlled trial will be to evaluate the effectiveness of treatment with transcutaneous electrical nerve stimulation (TENS) at reducing the level of fatigue experienced by people with MS.
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- University of Colorado, Boulder, Colorado
- Run by
- University of Colorado, Boulder
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.